Cargando…

NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway

N-myc down-regulated gene 1 (NDRG1) has been shown to regulate tumor growth and metastasis in various malignant tumors and also to be dysregulated in esophageal squamous cell carcinoma (ESCC). Here, we show that NDRG1 overexpression (91.9%, 79/86) in ESCC tumor tissues is associated with poor overal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ai, Runna, Sun, Yulin, Guo, Zhimin, Wei, Wei, Zhou, Lanping, Liu, Fang, Hendricks, Denver T., Xu, Yang, Zhao, Xiaohang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036407/ https://www.ncbi.nlm.nih.gov/pubmed/27414086 http://dx.doi.org/10.1080/15384047.2016.1210734

Ejemplares similares

Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma
por: Wei, Wei, et al.
Publicado: (2013)

Overexpression of stathmin plays a pivotal role in the metastasis of esophageal squamous cell carcinoma
por: Han, Gaijing, et al.
Publicado: (2017)

A novel rapid quantitative method reveals stathmin‐1 as a promising marker for esophageal squamous cell carcinoma
por: Yan, Lu, et al.
Publicado: (2018)

BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial–mesenchymal transition and angiogenesis
por: Zhao, Yan, et al.
Publicado: (2021)

A Prolyl-Hydroxylase Inhibitor, Ethyl-3,4-Dihydroxybenzoate, Induces Cell Autophagy and Apoptosis in Esophageal Squamous Cell Carcinoma Cells via Up-Regulation of BNIP3 and N-myc Downstream-Regulated Gene-1
por: Han, Bo, et al.
Publicado: (2014)

Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay
por: Jia, Kun, et al.
Publicado: (2016)

MARCKSL1 interacted with F‐actin to promote esophageal squamous cell carcinoma mobility by modulating the formation of invadopodia
por: Zhao, Yue, et al.
Publicado: (2022)

ETV5 overexpression promotes progression of esophageal squamous cell carcinoma by upregulating SKA1 and TRPV2
por: Sun, Ming-Chuang, et al.
Publicado: (2022)

NDRG1 protein overexpression in malignant thyroid neoplasms
por: Gerhard, Renê, et al.
Publicado: (2010)

Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma
por: Zhou, Li, et al.
Publicado: (2019)

GR, Sgk1, and NDRG1 in esophageal squamous cell carcinoma: their correlation with therapeutic outcome of neoadjuvant chemotherapy
por: Ueki, Shunsuke, et al.
Publicado: (2020)

Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells
por: Xu, Yang, et al.
Publicado: (2014)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma
por: Chen, Qiuyu, et al.
Publicado: (2023)

PURα Promotes the Transcriptional Activation of PCK2 in Esophageal Squamous Cell Carcinoma Cells
por: Sun, Yan, et al.
Publicado: (2020)

Overexpression of WRAP53 Is Associated with Development and Progression of Esophageal Squamous Cell Carcinoma
por: Rao, Xuguang, et al.
Publicado: (2014)

Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma
por: Zhang, Hang, et al.
Publicado: (2013)

NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Jing, Ji-sheng, et al.
Publicado: (2018)

YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice
por: Zhao, Nan, et al.
Publicado: (2015)

Overexpression of OLC1 Promotes Tumorigenesis of Human Esophageal Squamous Cell Carcinoma
por: Li, Xiao, et al.
Publicado: (2014)

HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma
por: Palumbo, Antonio, et al.
Publicado: (2016)

Forming cytoplasmic stress granules PURα suppresses mRNA translation initiation of IGFBP3 to promote esophageal squamous cell carcinoma progression
por: Tian, Lusong, et al.
Publicado: (2022)

Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
por: Yang, Boli, et al.
Publicado: (2021)

Targeted Overexpression of NDRG2 using Survivin Promoter Reduces Viability and Invasiveness of A549 Cell Line
por: Fanian, Maryam, et al.
Publicado: (2023)

Overexpression of Periostin and Lumican in Esophageal Squamous Cell Carcinoma
por: Kashyap, Manoj Kumar, et al.
Publicado: (2010)

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
por: Qiao, Yuanyuan, et al.
Publicado: (2017)

PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma
por: Qian, Zhaoye, et al.
Publicado: (2019)

Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers
por: Cangul, Hakan
Publicado: (2004)

Effects of NDRG2 Overexpression on Metastatic Behaviors of HCT116 Colorectal Cancer Cell Line
por: Golestan, Ali, et al.
Publicado: (2017)

Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
por: Yang, Boli, et al.
Publicado: (2022)

NDRG1 is expressed in human granulosa cells: An implicative role of NDRG1 in the ovary
por: Nishigaki, Akemi, et al.
Publicado: (2022)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
por: Xu, Shaohua, et al.
Publicado: (2022)

High expression of NDRG3 in osteoarthritis patients
por: Chen, Long, et al.
Publicado: (2021)

Overexpression of Peroxiredoxin 6 (PRDX6) Promotes the Aggressive Phenotypes of Esophageal Squamous Cell Carcinoma
por: He, Yan, et al.
Publicado: (2018)

Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma
por: Li, Minjuan, et al.
Publicado: (2020)

CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β-catenin pathway
por: Ju, Qianqian, et al.
Publicado: (2022)

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2013)

The Effects of NDRG2 Overexpression on Cell Proliferation and Invasiveness of SW48 Colorectal Cancer Cell Line
por: Golestan, Ali, et al.
Publicado: (2015)

Synergistic Effects of NDRG2 Overexpression and Radiotherapy on Cell Death of Human Prostate LNCaP Cells
por: Alizadeh Zarei, M., et al.
Publicado: (2017)

Overexpression of NDRG2 Increases Iodine Uptake and Inhibits Thyroid Carcinoma Cell Growth In Situ and In Vivo
por: Yin, Anqi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oh0j6ep20ajf8jps3oh5p8kipc